Anika Therapeutics Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Anika Therapeutics Stock Summary

Anika Therapeutics competes with Axogen, Orthofix Medical, SurModics, Paragon 28, and Artivion. Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts. Anika Therapeutics operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 297 people.

Anika Therapeutics Key Financial Ratios

Anika Therapeutics Key Balance Sheet Accounts

Anika Therapeutics Key Income Statement Accounts

Anika Therapeutics Key Cash Accounts

Anika Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Anika Therapeutics's current stock value. Our valuation model uses many indicators to compare Anika Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Anika Therapeutics competition to find correlations between indicators driving Anika Therapeutics's intrinsic value. More Info.Anika Therapeutics is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Anika Therapeutics' Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Anika Therapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Anika Therapeutics Systematic Risk

Today, most investors in Anika Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Anika Therapeutics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Anika Therapeutics growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Anika Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Anika Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Anika Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Anika Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Anika Therapeutics's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anika Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Anika Stock please use our How to buy in Anika Stock guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anika Therapeutics. If investors know Anika will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anika Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Anika Therapeutics is measured differently than its book value, which is the value of Anika that is recorded on the company's balance sheet. Investors also form their own opinion of Anika Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Anika Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anika Therapeutics' market value can be influenced by many factors that don't directly affect Anika Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Anika Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Anika Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anika Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.